Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?

Haematologica. 2007 Dec;92(12):1596-8. doi: 10.3324/haematol.11710.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Clinical Trials as Topic
  • Disease-Free Survival
  • Drug Evaluation* / psychology
  • Drug Evaluation* / trends
  • Hematologic Neoplasms / drug therapy*
  • Hematologic Neoplasms / mortality
  • Hematologic Neoplasms / psychology
  • Humans
  • Patient Participation* / psychology
  • Patient Participation* / trends
  • Quality of Life* / psychology
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents